Skip to content

    Immunocore Holdings (IMCR) stock price & financials

    View IMCR earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+12.2% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $80.25M
    $84.05M
    $93.88M
    $97.96M
    $103.69M
    +29.2%
    $104.48M
    +24.3%
    $106.68M
    +13.6%
    $115.93M
    +18.3%
    Strengthening
    Operating Profit
    -$8.50M
    -$19.45M
    -$3.62M
    -$14.88M
    -$7.17M
    +15.7%
    -$19.69M
    -1.2%
    $7.28M
    -$3.00M
    +79.9%
    Strengthening
    Net Profit
    $8.74M
    -$23.77M
    $5.02M
    -$10.30M
    -$177.0K
    -102.0%
    -$30.06M
    -26.5%
    $12.97M
    +158.2%
    -$808.0K
    +92.2%
    Strengthening
    EPS
    $0.17
    $0.10
    $-0.20
    $0.00
    -100.0%
    $0.26
    +160.0%
    $-0.02
    +90.0%
    Strengthening
    Other Income
    Interest
    $4.29M
    $7.04M
    $3.02M
    $3.04M
    $3.04M
    -29.1%
    $3.05M
    -56.6%
    $3.05M
    +0.9%
    $3.06M
    +0.6%
    Weakening
    Depreciation
    Profit before Tax
    $6.09M
    -$24.82M
    $6.08M
    -$9.69M
    $304.0K
    -95.0%
    -$15.79M
    +36.4%
    $13.27M
    +118.1%
    -$514.0K
    +94.7%
    Strengthening
    MarginsOPM
    -10.6%
    -23.1%
    -3.9%
    -15.2%
    -6.9%
    +34.7%
    -18.9%
    +18.5%
    6.8%
    -2.6%
    +83.0%
    Strengthening
    Tax
    -43.4%
    4.2%
    17.4%
    -6.3%
    158.2%
    -90.3%
    -2235.5%
    2.3%
    -87.0%
    -57.2%
    -815.2%
    Weakening
    ReturnsROIC
    -0.7%
    2.0%
    -0.4%
    0.8%
    0.0%
    2.5%
    +26.5%
    -1.1%
    -158.2%
    0.1%
    -92.2%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$321.08M$402.47M$442.63M$455.73M$467.71M$484.92M
    Short-Term Investments$0$364.64M$396.44M$395.29M
    Total Current Assets$473.98M$528.82M$929.86M$996.74M$1.05B
    Net PP&E$38.78M$42.73M$47.73M$50.24M$49.88M
    Goodwill
    Intangibles
    Total Assets$526.76M$597.00M$1.01B$1.07B$1.12B
    LiabilitiesTotal Current Liabilities$100.83M$139.02M$212.18M$246.70M$235.20M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$31.76M$35.61M$40.16M$41.56M$38.85M
    Total Liabilities$187.86M$228.16M$648.79M$686.24M$699.62M
    EquityCommon Stock & APIC$129.0K$134.0K$135.0K$136.0K$138.0K
    Retained Earnings-$689.39M-$744.67M-$795.76M-$831.27M-$819.11M
    Total Equity$233.71M$338.90M$368.84M$360.72M$381.03M$419.80M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$143.11M-$49.21M$2.94M$26.06M-$10.71M-$34.96M
    Cash from Investing-$1.28M-$2.20M-$5.42M-$355.13M-$16.34M$7.80M
    Cash from Financing$288.19M$145.44M$34.35M$343.88M$12.37M$23.29M
    SummaryCapital Expenditure-$1.39M-$2.20M-$5.42M-$5.17M-$4.34M-$6.20M
    Free Cash Flow-$144.49M-$51.41M-$2.48M$20.89M-$15.05M-$41.15M
    FCF Margin-396.0%-29.5%-1.0%6.7%-3.8%-9.6%

    Ratios